background
studi
fusioninhibitori
peptid
deriv
heptad
repeat
region
envelop
glycoprotein
provid
crucial
inform
viral
fusogen
mechan
use
similar
approach
studi
fusogen
mechan
severeacuterespiratorysyndromeassoci
coronaviru
sarscov
method
test
inhibitori
activ
infect
two
set
peptid
correspond
sequenc
sarscov
spike
protein
region
investig
interact
peptid
surfac
plasmon
reson
sediment
equilibr
analysi
circular
dichroism
nativ
polyacrylamidegel
electrophoresi
size
exclus
highperform
liquid
chromatographi
computeraid
homolog
model
molecul
dock
analysi
find
one
peptid
deriv
region
inhibit
sarscov
infect
micromolar
rang
bound
high
affin
peptid
region
alon
low
selfassoci
form
trimer
phosphat
buffer
ph
mix
equimolar
concentr
form
sixhelix
bundl
similar
fusogen
core
structur
interpret
bind
target
cell
transmembran
spike
protein
might
chang
conform
associ
region
form
oligomer
structur
lead
fusion
viral
targetcel
membran
prefus
intermedi
state
could
bind
region
interfer
conform
chang
result
inhibit
sarscov
fusion
target
cell
might
modifi
increas
antisarscov
activ
could
develop
antivir
agent
treatment
prophylaxi
sarscov
infect
global
outbreak
sever
acut
respiratori
syndrom
sar
serious
threaten
public
health
socioeconom
stabil
disord
caus
novel
coronaviru
sarsassoci
coronaviru
sarscov
angiotensinconvert
enzym
function
receptor
viru
mechan
sarscov
enter
target
cell
unclear
elucid
fusogen
mechan
provid
import
inform
develop
antivir
drug
vaccin
treatment
prevent
sar
sarscov
could
origin
wild
anim
similar
coronaviru
isol
anim
himalayan
palm
civet
coronaviru
share
genet
structur
properti
other
includ
murin
hepat
viru
bovin
coronaviru
exampl
sarscov
also
express
abund
spike
glycoprotein
surfac
trimer
dimer
structur
form
spike
nm
long
nm
wide
bulbou
end
spike
protein
sarscov
involv
viru
bind
fusion
entri
typic
class
viral
fusion
protein
similar
transmembran
glycoprotein
mani
envelop
virus
therefor
inform
obtain
studi
envelop
virus
could
use
investig
fusogen
mechan
mediat
sarscov
spike
protein
earli
wild
cowork
group
discov
potent
fusioninhibitori
peptid
deriv
heptad
repeat
region
design
npeptid
cpeptid
respect
one
cpeptid
trimeri
research
triangl
park
nc
usa
recent
approv
us
food
drug
administr
first
new
class
antihiv
drugsfus
inhibitor
studi
mechan
action
peptid
provid
import
inform
elucid
fusogen
mechan
mediat
bind
coreceptor
chang
interact
heptad
repeat
region
spike
protein
sarsassoci
coronaviru
implic
viru
fusogen
mechan
identif
fusion
inhibitor
occurr
group
seven
aminoacid
mani
time
protein
sequenc
seven
aminoacid
label
g
gener
hydrophob
other
hydrophil
method
measur
protein
molecular
mass
solut
studi
interact
protein
includ
associ
state
heterogen
thermodynam
properti
complex
form
six
rodlik
structur
rod
consist
peptid
conform
like
spring
three
peptid
form
central
trimer
core
three
peptid
pack
groov
surfac
central
trimer
core
person
use
reproduc
permiss
lancet
publish
group
aminoacid
sequenc
peptid
deriv
region
sarscov
spike
protein
similar
region
figur
similar
suggest
two
transmembran
envelop
glycoprotein
share
common
mechan
mediat
fusion
viral
targetcel
membran
similar
approach
use
studi
design
synthesis
seri
peptid
correspond
sequenc
sarscov
spike
protein
region
use
peptid
probe
studi
fusogen
mechan
viru
identifi
antivir
peptid
peptid
synthesis
appli
biosystem
pioneer
peptid
synthesis
abi
framingham
usa
standard
hexafluorophosph
hbtu
method
purifi
homogen
highperform
liquid
chromatographi
hplc
agil
technolog
palo
alto
ca
usa
characteris
maldi
tof
mass
spectromet
abi
voyag
de
foster
citi
ca
peptid
sequenc
shown
tabl
biotinyl
prepar
addit
biotin
hbtu
ntermini
peptid
synthesi
inhibitori
activ
synthet
peptid
sarscov
infect
vero
cell
assess
previous
describ
tcid
tissuecultur
infecti
dose
sarscov
whu
strain
access
number
mix
equal
volum
peptid
grade
concentr
incub
min
mixtur
ad
monolay
vero
cell
tissuecultur
plate
incub
h
supernat
remov
fresh
medium
ad
day
infect
cytopath
effect
record
concentr
peptid
result
inhibit
ic
calcul
measur
bind
affin
kinet
dissoci
constant
sarscov
relat
peptid
use
surfac
plasmon
reson
optic
biosensor
model
bia
biacor
inc
piscataway
nj
usa
biotinyl
moll
immobilis
streptavidin
sensor
chip
biacor
surfac
refer
biotinyl
bound
includ
analysi
derivatis
sensor
chip
wash
equilibr
phosphatebuff
salin
ph
lmin
peptid
test
introduc
five
serial
dilut
run
buffer
phosphatebuff
salin
ph
l
inject
volum
flow
rate
lmin
conform
via
interact
form
fusogen
hexamer
core
structur
bring
viral
targetcel
membran
close
proxim
result
fusion
intermedi
state
cpeptid
bind
viral
region
block
format
sixhelix
bundl
thu
inhibit
viru
fusion
target
cell
discoveri
fusioninhibitori
peptid
launch
new
line
investig
viral
fusogen
mechan
identif
antivir
peptid
infect
mani
envelop
virusessimian
felin
immunodefici
virus
ebola
viru
newcastl
diseas
viru
respiratori
syncyti
viru
similarli
domain
sarscov
spike
protein
contain
sequenc
tend
form
coiledcoil
structur
figur
associ
follow
min
dissoci
sensogram
respons
data
analys
commerci
softwar
biaevalu
version
kinet
dissoci
constant
calcul
experi
done
least
three
time
secondari
structur
peptid
determin
circulardichro
spectroscopi
previous
describ
isol
peptid
peptid
mixtur
dilut
phosphat
buffer
mmoll
sodium
phosphat
ph
final
concentr
moll
circulardichro
spectra
acquir
spectropolarimet
model
jasco
inc
japan
bandwidth
nm
resolut
nm
path
length
cm
respons
time
scan
speed
nmmin
thermal
denatur
monitor
nm
applic
thermal
gradient
spectra
correct
subtract
blank
correspond
solvent
melt
curv
smooth
midpoint
thermal
unfold
transit
tm
valu
calcul
jasco
softwar
util
previous
describ
appar
molecular
mass
peptid
peptid
mixtur
measur
sediment
equilibrium
analysi
beckman
coulter
optima
xli
analyt
ultracentrifug
equip
realtim
videobas
dataacquisit
system
rayleigh
optic
peptid
run
three
initi
concentr
moll
moll
moll
mmoll
sodium
phosphat
ph
contain
mmoll
sodium
chlorid
mmoll
tri
phosphin
hydrochlorid
sampl
volum
l
use
sixsector
cell
equip
quartz
window
experi
done
sediment
equilibrium
data
collect
rpm
rpm
rpm
complex
sediment
equilibrium
profil
edit
program
reedit
jeff
lari
nation
analyt
ultracentrifug
center
storr
ct
usa
analys
nonlinear
leastsquar
method
program
winnonlin
valu
partial
specif
volum
peptid
calcul
aminoacid
composit
program
sednterp
david
hay
magdalen
colleg
oxford
uk
tom
laue
univers
new
hampshir
durham
nh
usa
john
philo
amgen
thousand
oak
ca
usa
nativ
polyacrylamidegel
electrophoresi
npage
done
previous
describ
isol
peptid
peptid
mixtur
indic
concentr
mix
trisglycin
nativ
sampl
buffer
invitrogen
carlsbad
ca
usa
ratio
one
one
load
l
well
cm
trisglycin
precast
gel
gel
electrophoresi
carri
constant
v
room
temperatur
h
gel
stain
coomassi
blue
imag
taken
fluorchem
imag
system
alpha
innotech
corp
san
leandro
ca
usa
anoth
set
experi
mixtur
biotinyl
analys
npage
describ
peptid
gel
transfer
nitrocellulos
membran
amersham
pharmacia
biotech
inc
piscataway
nj
usa
block
nonfat
milk
overnight
follow
incub
streptavidinconjug
horseradish
peroxidas
room
temperatur
h
extens
wash
membran
stain
dye
imag
taken
describ
biosil
sec
column
mm
biorad
hercul
ca
usa
use
sizeexclus
hplc
sehplc
assess
oligom
format
peptid
incub
peptid
final
concentr
peptid
moll
min
l
sampl
inject
column
connect
hplc
system
water
delta
milford
usa
phosphatebuff
salin
ph
use
mobil
phase
flow
rate
mlmin
ultraviolet
absorb
nm
record
photodiod
array
detector
water
biorad
gelfiltr
processor
sgi
mountain
view
ca
usa
model
optimis
refin
option
model
use
conjug
gradient
togeth
molecular
dynam
simul
anneal
techniqu
five
model
run
built
model
lowest
object
function
select
protein
geometri
verifi
quanta
protein
health
check
result
model
evalu
stereochem
properti
procheck
softwar
use
dock
program
gramm
model
interact
peptid
dock
algorithm
predict
structur
protein
peptid
complex
maximis
geometr
match
imag
two
protein
peptid
molecul
detail
dock
approach
describ
elsewher
role
fund
sourc
fund
sourc
role
studi
design
collect
analysi
interpret
data
write
report
decis
submit
public
analys
spike
protein
sarscov
strain
predictprotein
program
protein
consist
sarscov
spike
protein
analys
probabl
form
coiledcoil
structur
use
program
multicoil
sequenc
submit
http
jurawimiteducgibinmulticoilmulticoilpl
predict
conform
complex
homolog
model
dock
techniqu
first
look
sequenc
align
peptid
correspond
npeptid
cpeptid
analysi
show
sequenc
similar
figur
use
xray
crystal
structur
core
structur
pdb
code
build
model
interact
sarscov
peptid
describ
align
npeptid
sarscov
npeptid
cpeptid
sarscov
cpeptid
use
program
clustalx
insert
delet
manual
adjust
avoid
gap
helix
region
homolog
model
peptid
built
autom
softwar
transmembran
domain
residu
intracellular
domain
residu
signal
peptid
residu
aminoterminu
observ
obviou
fusogen
peptid
sequenc
identifi
spike
protein
coronavirus
except
porcin
transmiss
gastroenter
viru
felin
infecti
periton
viru
cleavabl
cellular
proteas
yield
receptor
bind
viru
fusion
subunit
sarscov
spike
protein
contain
typic
cleavag
site
basic
aminoacid
sequenceeg
rrfrr
grhrr
krrsrr
therefor
boundari
domain
accur
identifi
present
coronaviru
spike
protein
domain
conserv
sequenc
domain
latter
compact
globular
structur
predict
predictprotein
program
globe
predict
globular
domain
contain
residu
residu
similar
class
viral
fusion
protein
analysi
multicoil
program
show
sequenc
region
tendenc
form
trimer
dimer
helix
bundl
consist
observ
coronaviru
spike
protein
homotrim
homodim
thu
region
may
take
part
oligomeris
conform
chang
spike
protein
viruscel
fusion
event
spike
protein
sarscov
pairwis
aminoacid
ident
correspond
protein
coronavirus
consist
observ
rota
colleagu
howev
ident
sequenc
much
higher
tabl
suggest
sequenc
region
conserv
sequenc
spike
protein
align
peptid
deriv
region
sarscov
spike
protein
reveal
high
sequenc
similar
npeptid
sarscov
npeptid
cpeptid
sarscov
cpeptid
respect
figur
thu
region
sarscov
spike
protein
may
share
certain
structur
function
featur
also
notic
residu
locat
posit
helic
wheel
hydrophob
figur
grey
box
conserv
b
c
f
posit
hydrophil
figur
white
box
featur
suggest
helic
form
homolog
oligom
hydrophob
associ
knobsintohol
pack
interact
posit
way
similar
interact
nhelic
core
residu
b
c
f
posit
form
hydrophil
face
toward
solut
make
oligomer
bundl
water
solubl
sinc
sequenc
sarscov
spike
protein
highli
similar
hypothesis
domain
similar
function
particip
viral
fusion
process
therefor
design
synthesis
six
peptid
overlap
sequenc
region
tabl
figur
peptid
rang
aminoacid
residu
length
tabl
molecular
mass
isol
peptid
complex
measur
sediment
equilibrium
ph
npeptid
random
coil
structur
solut
mix
equimolar
concentr
increas
figur
howev
chang
mix
mix
peptid
find
suggest
associ
form
complex
conform
helic
complex
rel
stabl
phosphat
buffer
tm
figur
cpeptid
interact
site
region
interfer
conform
chang
spike
protein
viral
fusion
process
identifi
bind
site
immobilis
biotinyl
streptavidin
sensor
chip
search
peptid
region
determin
surfac
plasmon
reson
biacor
strongli
bound
high
bind
affin
kinet
dissoci
constant
moll
figur
wherea
peptid
deriv
region
low
bind
activ
data
shown
tenresidu
shift
toward
cterminu
figur
tabl
bind
suggest
ntermin
residu
import
interact
ctermin
residu
interfer
bind
circulardichro
spectroscop
analysi
show
peptid
low
content
minima
nm
nm
phosphat
buffer
previous
shown
npage
peptid
interact
form
sixhelix
bundl
similar
approach
investig
whether
also
form
oligomer
complex
peptid
deriv
region
except
npeptid
show
band
gel
figur
carri
net
posit
charg
nativ
electrophoresi
condit
tabl
could
therefor
migrat
gel
migrat
gel
net
zero
charg
show
two
band
perhap
differ
conform
peptid
show
band
lower
part
gel
mixtur
show
two
band
lower
one
posit
isol
upper
one
expect
higher
order
oligomer
complex
form
confirm
whether
band
inde
repres
complex
form
analys
mixtur
biotinyl
differ
ratio
npage
two
gel
one
stain
coomassi
blue
figur
middl
gel
peptid
complex
anoth
gel
transfer
nitrocellulos
membran
stain
streptavidinconjug
horseradish
peroxidas
substrat
figur
lower
gel
increas
concentr
intens
upper
band
increas
lower
band
decreas
suggest
format
upper
band
depend
concentr
confirm
band
repres
aggreg
sinc
migrat
speed
molecul
complex
npage
depend
size
net
charg
molecul
complex
method
use
measur
exactli
molecular
mass
complex
gel
find
whether
lower
band
monom
oligom
therefor
analys
appar
molecular
mass
peptid
complex
sediment
equilibr
success
use
find
mass
sixhelix
bundl
form
npeptid
cpeptid
isol
monom
molecular
mass
obtain
correspond
trimer
phosphatebuff
salin
tabl
hplcpurifi
mixtur
show
complex
molecular
mass
da
figur
close
calcul
molecular
mass
trimer
dimer
result
confirm
sehplc
show
singl
peak
monom
major
peak
correspond
trimer
wherea
mixtur
show
three
peak
correspond
monom
trimer
trimer
heterodim
hexam
figur
find
suggest
monomer
structur
trimer
conform
phosphatebuff
salin
mix
equimolar
concentr
interact
form
sixhelix
bundl
consist
three
molecul
three
notion
consist
biophys
properti
npeptid
cpeptid
shown
sediment
equilibr
sehplc
align
peptid
correspond
npeptid
cpeptid
reveal
reason
sequenc
similar
gave
us
confid
homolog
model
associ
could
built
basi
xray
crystal
structur
core
form
npeptid
cpeptid
show
typic
coiledcoil
structur
figur
conform
except
kink
middl
structur
structur
possibl
complex
two
peptid
investig
use
specialis
proteindock
softwar
residu
posit
hydrophob
complex
structur
form
dock
techniqu
also
show
hydrophob
interact
two
peptid
eg
interact
well
respect
owe
lack
crystal
coordin
sequenc
beyond
nterminu
peptid
correspond
ntermin
sequenc
residu
could
model
interact
correspond
region
cterminu
could
predict
discoveri
peptid
fusion
inhibitor
elucid
mechan
action
provid
import
inform
explain
fusogen
mechan
envelop
virus
antisarscov
peptid
peptid
deriv
hr
region
spike
protein
use
probe
investig
role
region
process
sarscov
entri
target
cell
biophys
studi
show
peptid
deriv
region
sarscov
spike
protein
similar
properti
deriv
region
respect
exampl
like
npeptid
cpeptid
sarscov
interact
form
highord
oligomer
helic
may
import
role
fusion
sarscov
target
cell
basi
result
studi
knowledg
viral
transmembran
protein
propos
model
elucid
fusogen
mechan
mediat
sarscov
spike
protein
mechan
inhibit
sarscov
infect
figur
nativ
state
spike
protein
viru
surfac
could
oligomer
form
selfassoci
partli
helic
region
form
stem
spike
sarscov
region
may
random
coil
conform
cover
domain
bind
domain
receptor
eg
angiotensinconvert
enzym
target
cell
receptorbind
state
domain
chang
conform
form
extend
insert
inert
fusion
peptid
targetcel
membran
expos
region
intermedi
prehairpin
state
form
trimer
trimer
dissoci
monom
subsequ
monom
pack
onto
groov
trimer
form
sixhelix
bundl
fusionact
core
structur
bring
viral
targetcel
membran
close
proxim
result
fusion
membran
format
fusion
pore
allow
viru
genom
enter
target
cell
cpeptid
present
intermedi
state
could
bind
region
block
hexam
format
therebi
inhibit
fusion
howev
direct
evid
need
valid
model
nevertheless
inform
obtain
coronavirus
provid
indirect
evid
support
hypothesi
luo
colleagu
shown
spike
protein
murin
hepat
viru
like
contain
region
may
import
role
spikeproteinmedi
cellcel
fusion
viru
entri
doubl
alanin
substitut
four
middl
heptad
leucin
isoleucin
residu
within
region
lead
signific
reduct
fusion
activ
defect
spike
oligomeris
bosch
cowork
report
structur
function
characteris
fusion
core
complex
form
region
murin
hepat
viru
spike
protein
although
group
work
independ
distinct
coronavirus
differ
approach
obtain
surprisingli
similar
result
first
peptid
deriv
region
region
antivir
activ
second
peptid
deriv
murin
hepat
viru
sarscov
spike
protein
antivir
activ
micromolar
rang
third
fragment
involv
interact
spike
protein
virus
locat
region
find
suggest
murin
hepat
viru
sarscov
common
fusogen
mechan
may
share
coronavirus
peptid
deriv
region
sarscov
murin
hepat
viru
spike
protein
much
less
potent
inhibitori
activ
cpeptid
eg
activ
nanomolar
rang
sarscov
murin
hepat
viru
may
therefor
fusogen
mechan
differ
howev
peptid
deriv
region
mani
envelop
virus
includ
ebola
viru
newcastl
diseas
viru
parainfluenza
viru
respiratori
syncyti
viru
inhibit
correspond
viru
infect
also
micromolar
rang
virus
similar
fusogen
mechan
two
major
factor
affect
potenc
fusioninhibitori
peptid
sensit
viru
correspond
antivir
peptid
sequenc
conform
inhibitori
peptid
sensit
fusioninhibitori
peptid
correl
fusion
kinet
envelopecoreceptor
affin
receptor
densiti
figur
illustr
conform
chang
sarscov
spike
protein
process
fusion
viru
targetcel
membran
insight
viral
fusogen
mechan
gain
studi
peptid
fusion
inhibitor
sarscov
spike
glycoprotein
contain
heptad
repeat
sequenc
similar
envelop
glycoprotein
similar
might
help
elucid
mechan
sarscov
enter
target
cell
thu
could
implic
treatment
paper
assess
abil
synthesis
peptid
deriv
sarscov
region
inhibit
cytopath
effect
tissu
cultur
investig
interact
peptid
peptid
deriv
region
strong
inhibitori
activ
tissu
cultur
peptid
deriv
region
interact
form
sixhelix
structur
similar
fusogen
core
structur
find
confirm
carboxyl
termin
portion
spike
glycoprotein
sarscov
type
fusion
glycoprotein
possibl
fusogen
mechan
involv
bind
region
therebi
interf
conform
chang
lead
fusion
viral
targetcel
membran
lancet
vol
march
wwwthelancetcom
virus
might
differ
sensit
correspond
inhibitori
peptid
antivir
activ
peptid
fusion
inhibitor
depend
optimum
peptid
sequenc
conform
chang
sequenc
conform
could
substanti
affect
antivir
activ
stabil
complex
form
howev
optimis
peptid
sequenc
conform
could
improv
antivir
activ
therefor
use
lead
design
potent
antisarscov
peptid
drug
develop
use
peptid
treatment
sar
better
applic
antihiv
peptid
chemotherapi
aid
dose
need
treat
individu
acut
sarscov
infect
chronic
sar
report
wherea
hivinfect
individu
might
use
one
expens
antihiv
drug
life
furthermor
antisarscov
peptid
might
also
use
prophylact
nasal
spray
inhal
formul
protect
atrisk
popul
work
travel
sarsendem
area
peptid
deriv
region
sarscov
spike
protein
could
use
establish
highthroughput
assay
screen
nonpeptid
sarscov
fusion
inhibitor
success
develop
sever
assay
npeptid
cpeptid
identif
smallmolecul
fusion
inhibitor
compound
block
interact
could
use
lead
develop
viru
fusion
inhibitor
contributor
jiang
plan
direct
execut
project
liu
carri
npage
circular
dichroism
sehplc
analysi
g
xiao
viru
inhibit
assay
liu
g
xiao
made
equal
contribut
chen
h
xiong
carri
surfac
plasmon
reson
analysi
coordin
studi
j
niu
j
farmar
synthesis
peptid
c
r
escalant
carri
sediment
equilibr
analysi
k
debnath
molecular
model
dock
studi
p
tien
supervis
viru
inhibit
assay
